Thiogenesis Therapeutics, Corp. TTIPF
The SEC does not publish structured financial data (XBRL) for Thiogenesis Therapeutics, Corp., so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jun 9, 2026 | — |
| D | Filing | Aug 8, 2025 | — |
| D | Filing | Dec 20, 2023 | — |
| D | Filing | Nov 25, 2022 | — |
| D | Filing | Aug 11, 2021 | — |
Company profile
- Listed as
- TTIPF (OTC)
- Fiscal year ends
- February 28
- Incorporated in
- Ontario, Canada
- Headquarters
- Toronto, Ontario, Canada
- SEC CIK
- 1877778
- Former names
- Rozdil Capital Corp (until Aug 11, 2021)
Source: SEC EDGAR filings. This is company-reported data, not investment advice.